Mounjaro Ki Sales Mein 502% Ki Dhamaka, GLP-1 Market Mein

Arre bhai, Mounjaro toh chhaya hua hai! Eli Lilly ka yeh diabetes aur weight-loss ka jadoo, India mein sabse zyada bikne wala GLP-1 medicine ban gaya hai. August tak iski sales ₹1,256 crore tak pahunch gayi hai, growth toh 502% hai! Lagta hai logon ne injectables ko oral se zyada pasand karna shuru kar diya hai, jaise cricket mein sabko fast track chahiye!